Renaissance Technologies’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCRX
ECM
Renaissance Technologies's OCRX Position: Q1 2017 in Review
Renaissance Technologies sold out of Ocera Therapeutics (OCRX) in Q1 2017, closing a stake of 219,100 shares — an estimated $460K sold.
Renaissance Technologies first reported a position in OCRX in Q2 2013 and held it in 13 quarters. The position peaked at $491K in Q3 2016. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.
- Renaissance Technologies reported no remaining Ocera Therapeutics position as of Q1 2017 after selling out during the quarter.
- Renaissance Technologies sold 219,100 Ocera Therapeutics shares in Q1 2017, an estimated $460K.
- Renaissance Technologies first reported a position in Ocera Therapeutics in Q2 2013 and held it in 13 quarters.
- Renaissance Technologies's Ocera Therapeutics position peaked at $491K in Q3 2016.
- 26 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q1 2017.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.